Inhaled gene therapy for multiple lung nodules
Part of Cancer, Lungs & breathing clinical trials.
This trial tests an inhaled gene therapy (p53) to treat multiple ground-glass lung nodules that are precancerous or cancerous. If you have these nodules and good lung function, this treatment may stop the nodules from growing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have multiple ground-glass nodules (hazy spots on CT) with at least one between 0.5 cm and 3 cm.
- At least one of these nodules has been confirmed by a biopsy to be precancerous or cancerous.
- Your lung function is good (FEV1 at least 70% of normal).
- You are not pregnant or breastfeeding.
- You have no other active cancer in the last 5 years and no severe heart, liver, or kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new approach that combines two procedures in one session to treat multiple lung spots: one removed by a small surgery (VATS) and another destroyed using a needle guided by a robot and CT scan. It aims to save lung tissue while treating all spots at once.
This trial tests whether a targeted therapy pill (EGFR-TKI) can control small spots in the other lung after surgery for early-stage lung cancer. It's for people whose cancer has a specific EGFR gene change and who still have suspicious spots in the opposite lung after one side is removed.
This study looks at lung nodules found on CT scans. Researchers will collect data from your breathing tests and CT scans to better understand how these nodules relate to lung cancer.
This trial is testing a new treatment using your own immune cells (called NK cells) to fight leftover high-risk lung nodules that cannot be surgically removed. It is for people who have already had some cancerous nodules removed and are looking for another option.
This trial tests an immunotherapy approach to stop high-risk lung spots from turning into cancer. It is for people who are current or former heavy smokers with multiple slow-growing lung nodules that are not yet ready for surgery.
This trial tests a robotic procedure to safely take a sample from and treat small suspicious lung nodules without surgery. It may help patients who cannot or do not want traditional surgery or radiation therapy.
Hear when a new Lung Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.